EE309 Cost-Effectiveness of Mavacamten for the Treatment of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy in the Netherlands
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.575
https://www.valueinhealthjournal.com/article/S1098-3015(23)03705-1/fulltext
Section Title :
Section Order :
10066
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03705-1&doi=10.1016/j.jval.2023.09.575